Bertrand Brieau Selected Research

Drug Therapy (Chemotherapy)

12/2020	Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer.
1/2019	Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.
4/2016	Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.
1/2016	High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy.
9/2015	Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
1/2015	Resection of Late Pulmonary Metastases from Pancreatic Adenocarcinoma: Is Surgery an Option?
6/2013	Chemosensitivity in ovarian metastases from gastric cancer: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertrand Brieau Research Topics

Disease

4	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2020 - 09/2015
3	Neoplasm Metastasis (Metastasis) 04/2016 - 06/2013
2	Zenker Diverticulum (Zenker's Diverticulum) 01/2020 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 04/2016 - 06/2013
1	Neoplasms (Cancer) 08/2020
1	Obesity 07/2018
1	Cholelithiasis 07/2018
1	Mirizzi Syndrome 07/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Hemorrhage 10/2017
1	Colorectal Neoplasms (Colorectal Cancer) 10/2017
1	Residual Neoplasm 10/2017
1	Diarrhea 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Colitis 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Neuroendocrine Carcinoma 10/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Adenocarcinoma 01/2015

Drug/Important Bio-Agent (IBA)

3	PlatinumIBA 12/2020 - 09/2015
3	Gemcitabine FDA Link 01/2019 - 09/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	afliberceptIBA 10/2017
1	Capsules (Microcapsules)IBA 10/2017
1	Endothelial Growth FactorsIBA 10/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	177Lu-octreotateIBA 01/2016

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 12/2020 - 06/2013
3	Therapeutics 01/2019 - 10/2017
2	Myotomy 01/2020 - 01/2017
1	Pancreaticoduodenectomy 08/2020
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2018
1	Gastrostomy 07/2018
1	Laser Lithotripsy 07/2018
1	Bariatric Surgery 07/2018
1	Treatment Delay 01/2017
1	Ovariectomy (Oophorectomy) 04/2016
1	Chemoradiotherapy 10/2015